Table 1. Demographic, clinical, and immunologic characteristic of the patients studied
Variable |
n= 31 (%) |
|
Gender (M/F) |
13(42)/18(58) |
|
Age (years) ± SD |
46.27 ± 8.21 |
|
Disease severity |
|
|
Mild |
2 (15) |
3 (17) |
Moderate |
3 (23) |
6 (33) |
Severe |
8 (62) |
9 (50) |
Disease evolution (months) |
6.48 ± 3.33 |
|
antiAChR (nmol/L) ± SD |
1.55 ± 1.95 |
|
antiDsg3 (UI/mL) |
127.35 ± 64.35 |
|
BSA (%) |
41.32 ± 16.8 |
M/F = Male/Female
SD = Standard deviation
antiAChR = Anti-acetylcholine Receptor antibody
antiDsg3 = Anti-Desmoglein 3 antibody
BSA = Body Surface Area Affected
NS= Not significant.